Galderma, the Swiss skincare company renowned for its Cetaphil brand, has reported a remarkable 9.2% increase in sales during the first nine months of the year, totalling $3.26 billion. The firm credits this growth to robust product performance within both the skincare and injectable aesthetics categories across international markets, particularly in Europe, China, and Latin […]